|
125
|
564
|
3wlwA |
Molecular architecture of the erbb2 extracellular domain homodimer |
|
78
|
279
|
3zfmA |
Crystal structure of ephb2 |
|
93
|
293
|
3zclA |
X-ray structure of c-met kinase in complex with inhibitor (s)-3-(1-(1h-pyrrolo(2,3-b)pyridin-3-yl)ethyl)-n-isopropyl-(1,2,4)triazolo(4,3- b)pyridazin-6-amine |
|
113
|
564
|
3wsqA |
Structure of her2 with an fab |
|
99
|
317
|
3w32A |
Egfr kinase domain complexed with compound 20a |
|
92
|
320
|
3w2rA |
Egfr kinase domain t790m/l858r mutant with compound 4 |
|
66
|
306
|
3w13E |
Insulin receptor ectodomain construct comprising domains l1-cr in complex with high-affinity insulin analogue [d-pro-b26]-dti-nh2, alphact peptide(693-719) and fab 83-7 |
|
92
|
319
|
3w2sA |
Egfr kinase domain with compound4 |
|
97
|
321
|
3w2qA |
Egfr kinase domain t790m/l858r mutant with hki-272 |
|
1
|
11
|
3w11F |
Insulin receptor ectodomain construct comprising domains l1-cr in complex with human insulin, alpha-ct peptide(704-719) and fab 83-7 |
|
94
|
318
|
3w33A |
Egfr kinase domain complexed with compound 19b |
|
72
|
306
|
3w11E |
Insulin receptor ectodomain construct comprising domains l1-cr in complex with human insulin, alpha-ct peptide(704-719) and fab 83-7 |
|
94
|
328
|
3vw8A |
Crystal structure of human c-met kinase domain with its inhibitor |
|
95
|
321
|
3w2oA |
Egfr kinase domain t790m/l858r mutant with tak-285 |
|
68
|
306
|
3w12E |
Insulin receptor ectodomain construct comprising domains l1-cr in complex with high-affinity insulin analogue [d-pro-b26]-dti-nh2, alpha-ct peptide(704-719) and fab 83-7 |
|
2
|
11
|
3w12F |
Insulin receptor ectodomain construct comprising domains l1-cr in complex with high-affinity insulin analogue [d-pro-b26]-dti-nh2, alpha-ct peptide(704-719) and fab 83-7 |
|
2
|
11
|
3w13F |
Insulin receptor ectodomain construct comprising domains l1-cr in complex with high-affinity insulin analogue [d-pro-b26]-dti-nh2, alphact peptide(693-719) and fab 83-7 |
|
99
|
322
|
3w2pA |
Egfr kinase domain t790m/l858r mutant with compound 2 |
|
105
|
307
|
3vo3A |
Crystal structure of the kinase domain of human vegfr2 with imidazo[1,2-b]pyridazine derivative |
|
84
|
292
|
3v5qA |
Discovery of a selective trk inhibitor with efficacy in rodent cancer tumor models |
|
102
|
307
|
3vntA |
Crystal structure of the kinase domain of human vegfr2 with a [1,3]thiazolo[5,4-b]pyridine derivative |
|
0
|
8
|
3vrpB |
Crystal structure of the tyrosine kinase binding domain of cbl-c in complex with phospho-egfr peptide |
|
90
|
322
|
3vjnA |
Crystal structure of the mutated egfr kinase domain (g719s/t790m) in complex with amppnp. |
|
0
|
8
|
3vrrC |
Crystal structure of the tyrosine kinase binding domain of cbl-c (pl mutant) in complex with phospho-egfr peptide |
|
90
|
323
|
3vjoA |
Crystal structure of the wild-type egfr kinase domain in complex with amppnp. |
|
93
|
355
|
3vhkA |
Crystal structure of the vegfr2 kinase domain in complex with a back pocket binder |
|
103
|
359
|
3vheA |
Crystal structure of human vegfr2 kinase domain with a novel pyrrolopyrimidine inhibitor. |
|
30
|
199
|
3v6bR |
Vegfr-2/vegf-e complex structure |
|
88
|
356
|
3vidA |
Crystal structure of human vegfr2 kinase domain with compound a. |
|
29
|
198
|
3v2aR |
Vegfr-2/vegf-a complex structure |
|
86
|
322
|
3ug1A |
Crystal structure of the mutated egfr kinase domain (g719s/t790m) in the apo form |
|
77
|
302
|
3uimA |
Structural basis for the impact of phosphorylation on plant receptor-like kinase bak1 activation |
|
95
|
322
|
3ug2A |
Crystal structure of the mutated egfr kinase domain (g719s/t790m) in complex with gefitinib |
|
77
|
302
|
3ulzA |
Crystal structure of apo bak1 |
|
139
|
611
|
3u9uE |
Crystal structure of extracellular domain of human erbb4/her4 in complex with the fab fragment of mab1479 |
|
147
|
497
|
3u2pA |
Crystal structure of n-terminal three extracellular domains of erbb4/her4 |
|
87
|
305
|
3tt0A |
Co-structure of fibroblast growth factor receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (bgj398) |
|
92
|
304
|
3tl8A |
The avrptob-bak1 complex reveals two structurally similar kinaseinteracting domains in a single type iii effector |
|
74
|
287
|
3tcpA |
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase mer in complex with inhibitor unc569 |
|
37
|
176
|
3skjE |
Structural and functional characterization of an agonistic anti-human epha2 monoclonal antibody |
|
14
|
112
|
3s36X |
Structural basis for the function of two anti-vegf receptor antibodies |
|
22
|
112
|
3s35X |
Structural basis for the function of two anti-vegf receptor antibodies |
|
16
|
110
|
3s37X |
Structural basis for the function of two anti-vegf receptor antibodies |
|
94
|
323
|
5xdkA |
Crystal structure of egfr 696-1022 t790m in complex with co-1686 |
|
29
|
174
|
6b9lA |
Crystal structure of epha2 with peptide 135e2 |
|
80
|
324
|
5xgnA |
Crystal structure of egfr 696-1022 t790m/c797s in complex with go6976 |
|
73
|
313
|
3rcdA |
Her2 kinase domain complexed with tak-285 |
|
92
|
298
|
3ri1A |
Crystal structure of the catalytic domain of fgfr2 kinase in complex with arq 069 |
|
84
|
301
|
3rhxA |
Crystal structure of the catalytic domain of fgfr1 kinase in complex with arq 069 |
|
84
|
298
|
3rhkA |
Crystal structure of the catalytic domain of c-met kinase in complex with arq 197 |
